The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
May 19th 2024
With agents like semaglutide and tirzepatide becoming household drug names, Peterson discusses the short-term future of incretin drug development.
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Stroke Risk Among Older Patients with COVID-19 Most Apparent in First 3 Days of Diagnosis
February 12th 2022Data from Medicare beneficiaries provide insight into the risk of stroke associated with a diagnosis of COVID-19 among older adults, which results suggest peaks within the first 3 days of diagnosis.
Gestational Diabetes Raises Long-Term Risk of Multiple Cardiovascular Conditions
February 11th 2022AN analysis of the UK Biobank cohort provides insight into the increased risk of cardiovascular disease associated with gestational diabetes, including a 69% increase in risk of stroke and 42% increase in risk of heart failure later in life.
Study Suggests Risk of In-Hospital Mortality from Stroke 42% Greater During Pandemic
February 10th 2022A meta-analysis presented at ISC 2022 suggests the risk of in-hospital mortality for stroke-related admissions was 42% greater among patients hospitalized during the pandemic compared to prepandemic.
SCAI Releases New Statement on Sex-Based Considerations in Myocardial Revascularization
February 4th 2022Released on February 4, the latest expert consensus statement from the Society for Cardiovascular Angiography and Interventions provides clinicians with an overview of available knowledge related to myocardial revascularization in women and calls attention to existing gaps in knowledge.
Oxford–AstraZeneca COVID-19 Vaccine Associated with Small Excess Risk of Deep Venous Thrombosis
February 1st 2022Investigators noted that clinically relevant risks could not be excluded with certainty despite not seeing a statistically significant increase in corresponding risks for more rare and severe thrombotic outcomes.
SCAI Releases Updated Shock Classification Statement
February 1st 2022Released on Jan. 31, the updated consensus statement from the Society for Cardiovascular Angiography and Interventions provides a 3-axis model for shock classification and represents the first update since the original statement was released in 2019.